Entero Therapeutics secures $2M revolving loan, appoints three new directors
PremiumThe FlyEntero Therapeutics secures $2M revolving loan, appoints three new directors
2M ago
Entero Therapeutics Announces Board of Directors Restructuring
Premium
Company Announcements
Entero Therapeutics Announces Board of Directors Restructuring
2M ago
Entero Therapeutics announces proposed reverse merger with Journey Therapeutics
Premium
The Fly
Entero Therapeutics announces proposed reverse merger with Journey Therapeutics
5M ago
Entero Therapeutics Grapples with Financial Strain and Compliance Issues
PremiumCompany AnnouncementsEntero Therapeutics Grapples with Financial Strain and Compliance Issues
8M ago
Entero Therapeutics Issues Shareholder Update Letter
Premium
Company Announcements
Entero Therapeutics Issues Shareholder Update Letter
8M ago
Entero Therapeutics chairman issues letter to stockholders
Premium
The Fly
Entero Therapeutics chairman issues letter to stockholders
8M ago
Entero Therapeutics Executive Team Strategic Reshuffle
PremiumCompany AnnouncementsEntero Therapeutics Executive Team Strategic Reshuffle
10M ago
Entero Therapeutics presents two posters on celiac disease research at DDW 2024
Premium
The Fly
Entero Therapeutics presents two posters on celiac disease research at DDW 2024
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100